"Acceptable Adverse Event Profile?" At Six Months Follow-Up, the Pfizer-Vaccinated Had a 46% Increase in Mortality Compared to the Placebo Group

Of course they then vaccinated the placebo group.

The patients in the BNT162b2 (Pfizer) vaccine trial (Funded by BioNTech and Pfizer; ClinicalTrials.gov number, NCT04368728) were followed up to assess health outcomes.

From their data, 20 of 20,334 (98 per 100K) who received both doses of their experimental mRNA jab died.

In the placebo group, 14 out of 20794 (67 per 100K) had died.

The ratio 98/67 = 146; thus, 46% increase risk of all-cause death in the vaccinated compared to placebo.

The authors nevertheless concluded:

"Through 6 months of follow-up and despite a gradual decline in vaccine efficacy, BNT162b2 had a favorable safety profile".

and then

“BNT162b2 continued to be safe and have an acceptable adverse-event profile.”

This is on you, #NEJM. And on you, Pfizer. And on you, FDA.

And on you, the authors of the study.

Also from the study, in case any Attorneys General read #PopularRationalism:

“The authors’ full names, academic degrees, and affiliations are listed in the Appendix. Dr. Dormitzer can be contacted at philip.dormitzer@pfizer.com or at Pfizer, 401 N. Middletown Rd., Pearl River, NY 10965.”